Wenbin Liu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Donor-recipient age difference, not donor age alone, predicts outcomes in allogeneic hematopoietic stem cell transplantation for aplastic anemia.
Journal: Frontiers in immunology
Published: May 29, 2026
Gastrointestinal acute graft versus host disease: a translational perspective from pathogenesis to precision prevention and treatment.
Journal: Frontiers in immunology
Published: May 09, 2026
Cord blood transfusion added matched unrelated donor transplantation as a preferable choice for aplastic anaemia: a comparative study from a single centre.
Journal: Annals of medicine
Published: March 17, 2026
Romiplostim N01 accelerates platelet engraftment in autologousstem cell transplantation using non-cryopreserved peripheral blood stem cells for plasma cell neoplasms.
Journal: Frontiers in immunology
Published: February 20, 2026
Cyclosporine in hematological disorders: mechanisms, clinical practice and emerging advances.
Journal: Annals of hematology
Published: February 03, 2026
Comparison of clinical outcomes between early and delayed allogeneic hematopoietic stem cell transplantation for severe aplastic anemia: a single-center retrospective study.
Journal: Annals of hematology
Published: November 12, 2025
Superior outcomes with the FABT regimen in haploidentical transplantation for aplastic anemia in patients under 40 years old: a single-center retrospective study.
Journal: Clinical and experimental medicine
Published: October 28, 2025
A comparative study of the impact of lineal relatives versus collateral relatives donor on prognosis in haplo-HSCT for aplastic anemia.
Journal: Frontiers in immunology
Published: October 18, 2025
Novel FABT-Based Conditioning Regimen With Haploidentical Transplantation for Severe Aplastic Anemia: A Prospective, Single-Center, Phase II Clinical Trial.
Journal: Transplantation and cellular therapy
Published: October 13, 2025
Clinical Outcomes of Haploidentical Transplantation Combined With Umbilical Cord Blood and Mesenchymal Stem Cells Co-Infusion for Aplastic Anemia: A Single-Center Retrospective Study.
Journal: Transplantation proceedings
Published: September 29, 2025
Haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia: a single-center retrospective study.
Journal: Frontiers in medicine
Published: September 24, 2025
Efficacy and safety of hematopoietic stem cell transplantation vs. immunosuppressive therapy in patients with hepatitis-associated aplastic anemia: a systematic review and meta-analysis.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 09, 2025
Last Updated: 09/26/2026